You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4176 to 4200 of about 5897
Next 25
11/18/2006
Mayo Clinic Cancer Center -- Harnessing the Measles Virus to Attack Cancer
NCI Best Case Series for CAM: Outcomes in Treatment of Brain Tumors
Vaccine for brain tumors shows promising results
11/10/2006
Reata Announces Presentation of Interim Results for Phase 1 Study of RTA 744 in Treatment of Advanced Brain Tumors
Anti-cancer virus kills brain cancer cells
Jefferson Oncologists Show Less Radiation Just as Effective in Fighting Brain Tumor, Saving Hearing
A lesson in Living
Northwest Biotherapeutics Discusses Results From Clinical Trials In Brain Cancer At Two Conferences
Newly identified biomarker detects and regulates spread of brain tumors
Neurospheres Enriched in Cancer Stem-Like Cells Are Highly Effective in Eliciting a Dendritic Cell-Mediated Immune Response against Malignant Gliomas.
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.
Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas.
Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial.
Commercial flight and patients with intracranial mass lesions: a caveat. Report of two cases.
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
AACR Science Policy Alert
10/31/2006
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
10/30/2006
Added article: Treatments for Glioblastomas by Dr Marc Chamberlain
Northwest Biotherapeutics Discusses Results From Clinical Trials in Brain Cancer at Two Conferences
Mayo Clinic Cancer Center -- Harnessing the Measles Virus to Attack Cancer Seeking a Cure for Glioblastoma Multiforme, Other Deadly Cancers
10/26/2006
Reata Announces Receipt of Orphan Drug Status for RTA 744 in Treatment of Malignant Glioma
10/18/2006
Research Yields Clues to Radiation-Resistant Brain Cancer
10/17/2006
Have a Chance Walk for brain tumors.. NYC Oct 29, 2006
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.